Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	42.31	42.84	30.10
Graham Fair Price	-2.61	50.63	51.99
PEG	859.03	-2.03	0.21
Price/Book	26.94	6.08	4.79
Price/Cash Flow	927.19	220.20	21.44
Prices/Earnings	40.35	14.84	10.57
Price/Sales	67.38	5.41	3.23
Price/FCF	927.19	220.20	21.44
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	5.43	0.36	0.34
Operating Margin	20.31	0.12	0.10
ROA	-2.73	0.03	0.03
ROE	0.11	0.10	-9.55
ROIC	0.06	0.06	-0.89
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	36.42
Dividends QOQ	< 0.005	0.17	2507.06
EBIT QOQ	0.38	-0.06	-83.22
EPS QOQ	0.50	-0.07	-85.37
FCF QOQ	7.52	-0.87	-88.38
Revenue QOQ	0.27	-0.22	-19.25
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	100.86	149.81	48.53
Days Sales Outstanding (DSO)	2.76	4.82	74.40
Inventory Turnover	0.89	0.60	-32.67
Debt/Capitalization	0.43	0.42	-1.70
Quick Ratio	0.70	0.60	-14.12
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	32.57	33.35	2.40
Cash	22.41	20.46	-8.69
Capex	-2.21	-1.95	11.69
Free Cash Flow	7.28	0.92	-87.34
Revenue	48.23	37.46	-22.33
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.78	1.71	-3.87
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.94	5.99	21.23
Naive Interpretation	Member

06 - Financial Health · Weak

Rating